Arachidonic acid-induced human platelet aggregation independent of cyclooxygenase and lipoxygenase - PubMed (original) (raw)
Arachidonic acid-induced human platelet aggregation independent of cyclooxygenase and lipoxygenase
J Maclouf et al. Prostaglandins. 1984 Sep.
Abstract
It is generally agreed that arachidonic acid (20: 4 omega 6) can stimulate platelet aggregation after conversion to prostaglandin G2 and H2 and thence to thromboxane A2. This action is prevented by cyclooxygenase inhibitors. Washed platelets were isolated on metrizamide gradient and resuspended in a Ca2+-free buffer. Their stimulation by C 20: 4 6 was followed by 14C serotonin (5HT) release, thromboxane (TX) synthesis and an increase of light transmission, not dependent on aggregation, accompanied by slight lysis (14%). The addition of extrinsic Ca2+ suppressed lysis and allowed the formation of aggregates. Under these conditions, cyclooxygenase inhibitors such as acetyl salicylic acid, indomethacin or flurbiprofen totally suppressed TX synthesis without preventing platelet aggregation or [14C]-5HT release. Other C 20 polyunsaturated fatty acids could not substitute for C 20: 4 omega 6 in inducing aggregation, and Ca2+ was found to be a prerequisite for protection of the cell against lysis as well as for aggregation in the absence or TX formation. The use of the lipoxygenase inhibitor BW 755 C did not prevent C 20: 4 omega 6-induced aggregation of aspirin-treated platelets, suggesting that the phenomenon was independent of this pathway also. The total suppression of oxidative metabolism with these inhibitors was verified by the analysis of icosanoids using glass capillary column gas chromatography. It is suggested that under these conditions, C 20: 4 omega 6-induced platelet aggregation might be due to an increased membrane permeability to Ca2+ induced by this fatty acid in the absence of oxidation.
Similar articles
- Measurement of arachidonic acid liberation in thrombin-stimulated human platelets. Use of agents that inhibit both the cyclooxygenase and lipoxygenase enzymes.
Smith JB, Dangelmaier C, Mauco G. Smith JB, et al. Biochim Biophys Acta. 1985 Jul 9;835(2):344-51. doi: 10.1016/0005-2760(85)90290-5. Biochim Biophys Acta. 1985. PMID: 3924113 - Blockade of ADP-induced Ca2+-signal and platelet aggregation by lipoxygenase inhibitors.
Borin ML, Pinelis VG, Ivanova MA, Kudinov YuV, Azizova OA, Markov CM, Khodorov BI. Borin ML, et al. FEBS Lett. 1989 Nov 6;257(2):345-7. doi: 10.1016/0014-5793(89)81567-4. FEBS Lett. 1989. PMID: 2511040 - The effect of arachidonic acid metabolism on intravascular platelet aggregation in rats.
Mallarkey G, Smith GM. Mallarkey G, et al. Thromb Res. 1984 Oct 15;36(2):91-102. doi: 10.1016/0049-3848(84)90331-1. Thromb Res. 1984. PMID: 6438829 - Prostaglandin synthetase inhibitors. Drugs which affect arachidonic acid metabolism.
Whittle BJ. Whittle BJ. Acta Obstet Gynecol Scand Suppl. 1979;87:21-6. doi: 10.3109/00016347909157785. Acta Obstet Gynecol Scand Suppl. 1979. PMID: 111464 Review. - Physiological and pathophysiological roles of hepoxilins and their analogs.
Helal SA, Isse FA, Gerges SH, El-Kadi AOS. Helal SA, et al. Drug Metab Rev. 2023 Aug;55(3):254-266. doi: 10.1080/03602532.2023.2219035. Epub 2023 Jun 1. Drug Metab Rev. 2023. PMID: 37264550 Review.
Cited by
- A pilot study of the metabolic profiles of apheresis platelets modified by donor age and sex and in vitro short-term incubation with sex hormones.
Hadley JB, Kelher MR, D'Alessandro A, Gamboni F, Hansen K, Coleman J, Jones K, Cohen M, Moore EE, Banerjee A, Silliman CC. Hadley JB, et al. Transfusion. 2022 Dec;62(12):2596-2608. doi: 10.1111/trf.17165. Epub 2022 Oct 30. Transfusion. 2022. PMID: 36309927 Free PMC article. - Anti-inflammatory pharmacology and mechanism of the orally active capsaicin analogs, NE-19550 and NE-28345.
Brand LM, Skare KL, Loomans ME, Reller HH, Schwen RJ, Lade DA, Bohne RL, Maddin CS, Moorehead DP, Fanelli R, et al. Brand LM, et al. Agents Actions. 1990 Nov;31(3-4):329-40. doi: 10.1007/BF01997628. Agents Actions. 1990. PMID: 2128168 - Antiplatelet activity of 3-butyl-6-bromo-1(3H)-isobenzofuranone on rat platelet aggregation.
Ma F, Gao Y, Qiao H, Hu X, Chang J. Ma F, et al. J Thromb Thrombolysis. 2012 Jan;33(1):64-73. doi: 10.1007/s11239-011-0647-9. J Thromb Thrombolysis. 2012. PMID: 22057435 - Arachidonic acid-induced calcium influx in human platelets. Comparison with the effect of thrombin.
Alonso MT, Sanchez A, Garcia-Sancho J. Alonso MT, et al. Biochem J. 1990 Dec 1;272(2):435-43. doi: 10.1042/bj2720435. Biochem J. 1990. PMID: 2125206 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous